Skip to content

Author

G. Bellomo

We have 3 of 92 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Cerebrospinal fluid dopa-decarboxylase is a biomarker of dopaminergic dysfunction

CSF DDC reflects nigrostriatal dopaminergic dysfunction, representing a potential quantitative biochemical alternative to DaT-SPECT that might be readily implemented via automated immunoassays.

S. Sperandei, F. P. Paoletti, M. Depauw et al. · 0 citations
Open access Sep 2026

Application of unsupervised and supervised machine learning approaches to blood-based biomarkers of Alzheimer’s disease in a memory clinic cohort

The results prove that clustering approaches can help in identifying reliable BBMs cutoffs for AD diagnosis even in the absence of CSF gold standard reference and that ML approaches combining multiple BBMs can strongly enhance their diagnostic accuracy.

Edoardo Guido Torrigiani, D. Cianca, L. Gaetani et al. · 0 citations
Sep 2026

Toward harmonized reporting of Alzheimer’s disease biomarkers in clinical practice

The principles of harmonized reporting for Alzheimer’s disease biomarkers and a structured framework for standardized clinical neurochemistry reports are discussed and a structured framework for standardized clinical neurochemistry reports is proposed.

L. Agnello, Andrea Pilotto, L. Gaetani et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.